SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
LUCIER GREGORY T
(Last) (First) (Middle)
5791 VAN ALLEN WAY
(Street)
CARLSBAD CA 92008
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Life Technologies Corp [ LIFE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/03/2014
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 02/03/2014 D 456,046 D $76.1312 0 I By Trust
Common Stock(1) 02/03/2014 D 28,945 D $76.1312 0 D
Common Stock(1)(2) 02/03/2014 D 81,071.86 D $76.1312 0 I By Employee Benefit Plan Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options $52 02/03/2014 D 243,407 03/01/2011 03/01/2020 Common Stock 243,407 $52(3) 0 D
Stock Options $48.91 02/03/2014 D 160,028 04/02/2013 04/02/2022 Common Stock 160,028 $48.91(3) 0 D
Stock Options $38.43 02/03/2014 D 85,000 05/13/2006 05/13/2015 Common Stock 85,000 $38.43(3) 0 D
Stock Options $37.33 02/03/2014 D 210,000 03/01/2007 03/01/2016 Common Stock 210,000 $37.33(3) 0 D
Stock Options $32.69 02/03/2014 D 92,768 05/14/2005 05/14/2014 Common Stock 92,768 $32.69(3) 0 D
Stock Options $32.26 02/03/2014 D 85,000 11/14/2006 11/14/2015 Common Stock 85,000 $32.26(3) 0 D
Stock Options $31.26 02/03/2014 D 70,000 11/12/2005 11/12/2014 Common Stock 70,000 $31.26(3) 0 D
Stock Options $22.23 02/03/2014 D 485,829 11/21/2012 11/14/2018 Common Stock 485,829 $22.23(3) 0 I By Trust(4)
Restricted Stock Units (1) 02/03/2014 D 17,423 04/01/2014 04/03/2017 Common Stock 17,423 (5) 52,268 D
Restricted Stock Units (1) 02/03/2014 D 52,268 04/01/2014 04/03/2017 Common Stock 52,268 (6) 0 D
Restricted Stock Units (1) 02/03/2014 D 69,003 04/02/2013 04/04/2016 Common Stock 69,003 (6) 0 D
Restricted Stock Units (1) 02/03/2014 D 75,060 04/01/2012 04/01/2021 Common Stock 75,060 (6) 0 D
Restricted Stock (1) 02/03/2014 D 6,427.15 01/07/2014 01/07/2017 Common Stock 6,427.15 (7) 0 D
Restricted Stock (1) 02/03/2014 D 2,136.08 03/15/2016 03/15/2016 Common Stock 2,136.08 (7) 0 D
Restricted Stock (1) 02/03/2014 D 2,106.14 03/09/2015 03/09/2015 Common Stock 2,106.14 (7) 0 D
Restricted Stock (1) 02/03/2014 D 3,494.84 03/11/2014 03/11/2021 Common Stock 3,494.84 (7) 0 D
Explanation of Responses:
1. On February 3, 2014, Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), acquired the issuer pursuant to that certain merger agreement between issuer, Thermo Fisher and Polpis Merger Sub Co., a Delaware corporation and wholly owned subsidiary of Thermo Fisher ("Merger Sub"), dated as of April 14, 2013 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the issuer (the "Merger"), with the issuer surviving the Merger as a wholly owned subsidiary of Thermo Fisher. At the effective time of the Merger, each outstanding share of the issuer's common stock was converted into the right to receive $$76.1311786 in cash (the "per-share merger consideration"). In addition, all outstanding options, performance restricted stock units and service-based restricted stock units were canceled at the effective time of the Merger in exchange for a cash payment equal to the per-share merger consideration (less the exercise price in the case of options), payable without interest and less any required withholding taxes (other than certain service-based restricted stock units that were assumed by Thermo Fisher at the effective time of the Merger and converted into the right to receive a cash payment equal to the per-share merger consideration, which will vest and become payable following the effective time of the Merger in accordance with their original terms). The Merger is more fully described in the issuer's Proxy Statement filed with the SEC on July 22, 2013.
2. Common stock issued under Deferred Compensation Plan.
3. These Stock Options, which provided for vesting in four equal annual installments beginning on the first anniversary of the date of the grant, were canceled at the effective time of the Merger (whether vested or unvested) in exchange for a cash payment equal to the per-share merger consideration, less the exercise price of the option.
4. Shares held in the Greg T. and Marilena Lucier Revocable Living Trust.
5. These service-based Restricted Stock Units, which provided for vesting in four equal annual installments beginning on the first anniversary of the date of the grant, were canceled at the effective time of the Merger in exchange for a cash payment equal to the per-share merger consideration.
6. These service-based Restricted Stock Units, which provided for vesting in four equal annual installments beginning on the first anniversary of the date of the grant, were assumed by Thermo Fisher at the effective time of the Merger and converted into the right to receive a cash payment equal to the per-share merger consideration, which will vest and become payable following the effective time of the Merger in accordance with their original terms.
7. These service-based Restricted Stock Units, which were issued under the Deferred Compensation Plan matching program and provided for vesting on the third anniversary of the time the match was made, were canceled at the effective time of the Merger in exchange for a cash payment equal to the per-share merger consideration.
John Cottingham, attorney-in-fact for Mr. Lucier 02/04/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.